+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Serum-Free Media Market by Cell Type (Mammalian Cells, Non-Mammalian Cells), Product Type (Custom Media, Defined Media), Formulation, Application, End User - Global Forecast 2025-2030- Product Image
Serum-Free Media Market by Cell Type (Mammalian Cells, Non-Mammalian Cells), Product Type (Custom Media, Defined Media), Formulation, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Serum-Free Media Market by Cell Type (Mammalian Cells, Non-Mammalian Cells), Product Type (Custom Media, Defined Media), Formulation, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6084041
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Serum-Free Media Market is experiencing dynamic transformation as life sciences organizations shift toward chemically defined media to enhance bioproduction quality and regulatory compliance. Heightened demand from biopharmaceutical and cell therapy sectors is accelerating both innovation and competition across global value chains.

Market Snapshot: Serum-Free Media Market Growth and Outlook

The Serum-Free Media Market grew from USD 1.62 billion in 2024 to USD 1.74 billion in 2025. It is expected to continue growing at a CAGR of 7.73%, reaching USD 2.53 billion by 2030. Key drivers include steady adoption in biopharmaceutical process development, expanding use in cell and gene therapy, and increased focus on defined, animal-origin-free media for reproducibility and regulatory acceptance.

Scope & Segmentation

This comprehensive analysis covers primary segments, application domains, and geographic regions shaping the market.

  • Cell Type: Mammalian cell platforms (CHO, NS0, Vero), non-mammalian systems (insect and yeast cells), each presenting unique nutrient and performance requirements.
  • Product Type: Custom media tailored for specialized research and production, and defined media for standardized workflows.
  • Formulation: Liquid forms supporting rapid deployment and high-throughput settings, powdered forms valued for storage and cost efficiency in manufacturing operations.
  • Application: Academic research, biopharmaceutical production (including monoclonal antibodies, recombinant proteins, vaccines), cell & gene therapy (with a focus on emerging modalities), and tissue engineering.
  • End User: Biotechnology companies, contract research organizations, and pharmaceutical enterprises each with specific quality and compliance priorities.
  • Geographies: Americas (with focus on the United States and key states), Europe, Middle East & Africa (EUMEA), and Asia-Pacific (APAC), reflecting divergent growth trends and regulatory landscapes.
  • Companies Profiled: Major players include Thermo Fisher Scientific, Merck KGaA, Lonza, Corning, Cytiva, and leading innovators like STEMCELL Technologies Canada Inc., Sartorius AG, and Sino Biological, Inc., among others.

Key Takeaways for Senior Decision-Makers

  • Serum-free media adoption is integral for reproducibility and process consistency, addressing the need for regulatory clarity in commercial-scale bioproduction.
  • Technological advances—such as high-throughput analytics, omics-informed nutrient design, and proprietary additives—are enabling reliable performance across diverse and complex cell lines.
  • The move toward single-use bioreactor systems and integration of digital process controls is streamlining manufacturing workflows and minimizing contamination risks.
  • Regional opportunities are expanding, especially in the Asia-Pacific market, where scalability and cost efficiency are driving rapid uptake and supplier investment.
  • Companies are differentiating through modular service models that blend defined base media with customizable additive packages to support cutting-edge therapeutic programs.
  • The competitive landscape is shifting toward integrated service offerings, as partnerships between manufacturers, raw material suppliers, and CROs gain momentum.

Tariff Impact on Supply Chain and Cost Structures

The introduction of United States tariffs in 2025 has materially influenced the pricing and sourcing strategies for serum-free media components. Suppliers are pivoting to domestic production partnerships and regional sourcing to bolster resilience, while buyers are increasingly turning to media optimization and volume-based contracts to stabilize margins. The tariff backdrop is also prompting stakeholders to consider vertical integration as a buffer against future regulatory shifts, thereby reshaping industry supply chains.

Methodology & Data Sources

This report integrates primary insights from bioprocess stakeholders with secondary sources such as published research, regulatory data, and patent analysis. Analytical frameworks, including SWOT assessments and value chain mapping, validate trends and ensure data accuracy.

Serum-Free Media Market: Why This Report Matters

  • Empowers leaders to optimize R&D, procurement, and manufacturing strategies amid shifting technology and regulatory environments.
  • Delivers actionable segmentation and competitor insights to support targeted growth, M&A, and supplier negotiations in this evolving landscape.

Conclusion

The Serum-Free Media Market is poised for significant evolution, driven by technology, regulation, and strategic partnerships. Organizations leveraging scientific innovation and resilient supply approaches will shape the next era of bioproduction success.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of chemically defined serum-free media for consistent biopharmaceutical production
5.2. Integration of single-use bioreactors with optimized serum-free media for cell therapy scale-up
5.3. Development of plant-derived recombinant growth factors to replace animal serum components in cultures
5.4. Adoption of serum-free media in stem cell manufacturing to meet stringent regulatory standards
5.5. Advancements in high-throughput screening platforms for rapid serum-free media formulation optimization
5.6. Rising demand for cGMP-grade serum-free media in monoclonal antibody production to ensure quality
5.7. Shift towards synthetic peptide supplements to eliminate batch variability in serum-free cell cultures
5.8. Ai-driven predictive modeling platforms accelerating serum-free media customization for diverse cell lines
5.9. Modular media formulation kits enabling point-of-care customization for advanced cell therapy pipelines
5.10. Subscription-based digital platforms offering formulation support and analytics for serum-free media customers
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Serum-Free Media Market, by Cell Type
8.1. Introduction
8.2. Mammalian Cells
8.2.1. CHO Cells
8.2.2. NS0 Cells
8.2.3. Vero Cells
8.3. Non-Mammalian Cells
8.3.1. Insect Cells
8.3.2. Yeast Cells
9. Serum-Free Media Market, by Product Type
9.1. Introduction
9.2. Custom Media
9.3. Defined Media
10. Serum-Free Media Market, by Formulation
10.1. Introduction
10.2. Liquid Form
10.3. Powdered Form
11. Serum-Free Media Market, by Application
11.1. Introduction
11.2. Academic Research
11.2.1. Gene Editing
11.2.2. Stem Cell Research
11.3. Biopharmaceutical Production
11.3.1. Monoclonal Antibodies
11.3.2. Recombinant Proteins
11.3.3. Vaccines
11.4. Cell & Gene Therapy
11.4.1. CAR-T Therapy
11.4.2. Stem Cell Therapy
11.5. Tissue Engineering
12. Serum-Free Media Market, by End User
12.1. Introduction
12.2. Biotechnology Companies
12.3. Contract Research Organizations
12.4. Pharmaceutical Companies
13. Americas Serum-Free Media Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Serum-Free Media Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Serum-Free Media Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Ajinomoto Co., Inc.
16.3.2. Becton, Dickinson and Company
16.3.3. Bio-Techne Corporation
16.3.4. Biowest
16.3.5. Celprogen Inc.
16.3.6. Corning Incorporated
16.3.7. Danahar Corporation
16.3.8. FUJIFILM Holdings Corporation
16.3.9. Gmep Incorporated
16.3.10. HiMedia Laboratories Private Limited
16.3.11. Jimi Biotech
16.3.12. Kyokuto Pharmaceutical Industrial Co., Ltd
16.3.13. Leinco Technologies, Inc.
16.3.14. Lonza Group
16.3.15. Merck KgaA
16.3.16. Myoridge Co. Ltd.
16.3.17. Nucleus Biologics
16.3.18. PAN-Biotech GmbH
16.3.19. R&D Systems, Inc.
16.3.20. REPROCELL Inc.
16.3.21. Sartorius AG
16.3.22. Shanghai BioEngine Sci-Tech Co, Ltd
16.3.23. Shanghai Excell Biological Technology Co., Ltd.
16.3.24. Sino Biological, Inc.
16.3.25. STEMCELL Technologies Canada Inc.
16.3.26. Thermo Fisher Scientific Inc.
16.3.27. TransGen Biotech Co., Ltd.
16.3.28. ZenBio, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SERUM-FREE MEDIA MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL SERUM-FREE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. SERUM-FREE MEDIA MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. SERUM-FREE MEDIA MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. SERUM-FREE MEDIA MARKET: RESEARCHAI
FIGURE 26. SERUM-FREE MEDIA MARKET: RESEARCHSTATISTICS
FIGURE 27. SERUM-FREE MEDIA MARKET: RESEARCHCONTACTS
FIGURE 28. SERUM-FREE MEDIA MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. SERUM-FREE MEDIA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SERUM-FREE MEDIA MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL SERUM-FREE MEDIA MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY NS0 CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY NS0 CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY VERO CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY VERO CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY INSECT CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY INSECT CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY YEAST CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY YEAST CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CUSTOM MEDIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CUSTOM MEDIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY DEFINED MEDIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY DEFINED MEDIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY LIQUID FORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY LIQUID FORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY POWDERED FORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY POWDERED FORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY GENE EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CAR-T THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CAR-T THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 123. CANADA SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 124. CANADA SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 125. CANADA SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 126. CANADA SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 127. CANADA SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 128. CANADA SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 129. CANADA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. CANADA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. CANADA SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 132. CANADA SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 133. CANADA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. CANADA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. CANADA SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 136. CANADA SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 137. CANADA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
TABLE 138. CANADA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
TABLE 139. CANADA SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 140. CANADA SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 141. CANADA SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. CANADA SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 146. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 147. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 148. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 149. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 152. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 153. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 156. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 157. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
TABLE 158. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
TABLE 159. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 160. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 161. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 246. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 247. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 248. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 249. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 250. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 251. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 252. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 253. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 254. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 255. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 258. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 259. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
TABLE 260. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
TABLE 261. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 262. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 263. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 266. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 267. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 268. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 269. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 270. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 271. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 274. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 275. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 278. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 279. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
TABLE 280. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
TABLE 281. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 282. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 283. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. ITALY SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 306. ITALY SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 307. ITALY SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 308. ITALY SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 309. ITALY SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 310. ITALY SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 311. ITALY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 312. ITALY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 313. ITALY SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 314. ITALY SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 315. ITALY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 316. ITALY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 317. ITALY SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 318. ITALY SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 319. ITALY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
TABLE 320. ITALY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
TABLE 321. ITALY SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 322. ITALY SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 323. ITALY SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. ITALY SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 326. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 327. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 328. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 329. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2024 (USD MILLION)
TABLE 330. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2025-2030 (USD MILLION)
TABLE 331. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 332. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 333. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 334. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 335. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 336. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 337. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 338. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 339. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
TABLE 340. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
TABLE 341. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 342. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 343. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 344. SPAIN SERUM-FREE MEDIA MARKET SI

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Serum-Free Media market report include:
  • Ajinomoto Co., Inc.
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • Biowest
  • Celprogen Inc.
  • Corning Incorporated
  • Danahar Corporation
  • FUJIFILM Holdings Corporation
  • Gmep Incorporated
  • HiMedia Laboratories Private Limited
  • Jimi Biotech
  • Kyokuto Pharmaceutical Industrial Co., Ltd
  • Leinco Technologies, Inc.
  • Lonza Group
  • Merck KgaA
  • Myoridge Co. Ltd.
  • Nucleus Biologics
  • PAN-Biotech GmbH
  • R&D Systems, Inc.
  • REPROCELL Inc.
  • Sartorius AG
  • Shanghai BioEngine Sci-Tech Co, Ltd
  • Shanghai Excell Biological Technology Co., Ltd.
  • Sino Biological, Inc.
  • STEMCELL Technologies Canada Inc.
  • Thermo Fisher Scientific Inc.
  • TransGen Biotech Co., Ltd.
  • ZenBio, Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.74 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.53 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Cell Culture Media Market by Product Type (Serum-Containing Media, Serum-Free Media), Cell Type (Mammalian Cell Culture Media, Microbial And Insect Cell Culture Media, Plant Cell Culture Media), Form, Application, End User - Global Forecast 2025-2030 - Product Image

Cell Culture Media Market by Product Type (Serum-Containing Media, Serum-Free Media), Cell Type (Mammalian Cell Culture Media, Microbial And Insect Cell Culture Media, Plant Cell Culture Media), Form, Application, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Serum-free Media Market Size, Share & Trends Analysis Report By Solution, By Product, By Application, By End-use, By Type, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Serum-free Media Market Size, Share & Trends Analysis Report By Solution, By Product, By Application, By End-use, By Type, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Serum-free T Cell Expansion Medium Market by Format, Technology, Application, Cell Type, End User - Global Forecast to 2030 - Product Image

Serum-free T Cell Expansion Medium Market by Format, Technology, Application, Cell Type, End User - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Cell Culture Media Market Size, Share & Trends Analysis Report By Product (Serum-free Media, Classical Media), By Type (Liquid Media, Semi-solid And Solid Media), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Cell Culture Media Market Size, Share & Trends Analysis Report By Product (Serum-free Media, Classical Media), By Type (Liquid Media, Semi-solid And Solid Media), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Serum-Free Media - Global Strategic Business Report - Product Image

Serum-Free Media - Global Strategic Business Report

  • Report
  • 476 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.